Diagnostic variation and outcome for high-grade gastric epithelial dysplasia

Archives of Surgery

Volumn 140, Issue 7, 2005, Pages 644-649

  Sarela, Abeezar I ^a,b   Scott, Nigel ^a   Verbeke, Caroline S ^a   Wyatt, Judy I ^a   Dexter, Simon P L ^a   Sue Ling, Henry M ^a   Guillou, Pierre J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EPITHELIUM DYSPLASIA; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; SAMPLE SIZE; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CARCINOMA; STOMACH EPITHELIUM; STOMACH MUCOSA; TISSUE SECTION; CANCER STAGING; CARCINOMA; COMPARATIVE STUDY; GASTROSCOPY; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH TUMOR; SURVIVAL;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA; COHORT STUDIES; FEMALE; GASTROSCOPY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 23244446477     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.140.7.644     Document Type: Article

References (27)

1. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol. 2000;24:167-176.
2. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
3. Al Kasspooles MF, Hill HC, Nava HR, Smith JL, Douglass HO, Gibbs JF. High-grade dysplasia within Barrett's esophagus: controversies regarding clinical opinions and approaches. Ann Surg Oncol. 2002;9:222-227.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-6740.
5. Rugge M, Cassaro M, Di Mario F, et al. The long term outcome of gastric non-invasive neoplasia. Gut. 2003;52:1111-1116.
6. Lauwers GY, Riddell RH. Gastric epithelial dysplasia. Gut. 1999;45:784-790.
7. Schlemper RJ, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet. 1997;349: 1725-1729.
8. Altman DG. Inter-rater agreement. In: Practical Statistics for Medical Research. London, England: Chapman and Hall; 1995:403-409.
9. Lauwers GY, Shimizu M, Correa P, et al. Evaluation of gastric biopsies for neoplasia: differences between Japanese and Western pathologists. Am J Surg Pathol. 1999;23:511-518.
10. Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut. 2002;51:671-676.
11. Weinstein WM, Goldstein NS. Gastric dysplasia and its management. Gastroenterology. 1994;107:1543-1545.
12. Saraga EP, Gardiol D, Costa J. Gastric dysplasia: a histological follow-up study. Am J Surg Pathol. 1987;11:788-796.
13. Lansdown M, Quirke P, Dixon MF, Axon AT, Johnston D. High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut. 1990;31:977-983.
14. Fertitta AM, Comin U, Terruzzi V, et al. Clinical significance of gastric dysplasia: a multicenter follow-up study. Gastrointestinal Endoscopic Pathology Study Group. Endoscopy. 1993;25:265-268.
15. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology. 1993;105:40-50.
16. Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut. 2000;47:618-621.
17. Everett SM, Axon AT. Early gastric cancer: disease or pseudo-disease? Lancet. 1998;351:1350-1352.
18. Coma del Corral MJ, Pardo-Mindan FJ, Razquin S, Ojeda C. Risk of cancer in patients with gastric dysplasia: follow-up study of 67 patients. Cancer. 1990;65:2078-2085.
19. Farinati F, Rugge M, Di Mario F, Valiante F, Baffa R. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients: a prospective study. I.G.G.E.D. - Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy. 1993;25:261-264.
20. Rugge M, Cassaro M, Pennelli G, Russo VM, Di Mario F, Farinati F. Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions. Gut. 2003;52:453-454.
21. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225-229.
22. Bhunchet E, Hatakawa H, Sakai Y, Shibata T. Fluorescein electronic endoscopy: a novel method for detection of early stage gastric cancer not evident to routine endoscopy. Gastrointest Endosc. 2002;55:562-571.
23. Ohashi S, Segawa K, Okamura S, et al. The utility of endoscopic ultrasonography and endoscopy in the endoscopic mucosal resection of early gastric cancer. Gut. 1999;45:599-604.
24. Rugge M, Farinati F, Baffa R, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology. 1994;107:1288-1296.
25. O'Mahony S. Endoscopic mucosal resection for early gastric cancer. Gut. 2001;48:151-152.
26. Sagawa T, Takayama T, Oku T, et al. Argon plasma coagulation for successful treatment of early gastric cancer with intramucosal invasion. Gut. 2003;52:334-339.
27. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst. 2000;92:1881-1888.